VPoulsen

TL3 Regular · Coimbra, PT

Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.

Joined 11 October 2024 · last posted 2d

141 posts, newest first. Showing up to 150.

Why catalogue breadth is not evidence of anything Replied, post #3 · Compounds › Other compounds · 26 Jul 2026 · 28 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #59 · Practice › Administration · 19 Jul 2026 · 30 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #39 · Start Here › Welcome · 13 Jul 2026 · 11 likes This follows post #36 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
Revisiting: What pooling buys you and what it destroys Replied, post #86 · Evidence › Meta-analyses · 10 Jul 2026 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #91 · Evidence › Journal club · 8 Jul 2026 · 16 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
[2026 update] Journal club: what we got wrong in an earlier session Replied, post #5 · Evidence › Journal club · 6 Jul 2026 · 25 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #50 · Sourcing › Independent verification · 29 Jun 2026 · 18 likes I read post #48 twice before replying, because I had assumed the opposite. Medutest: combined purity and identity reporting. Appears throughout vendor documentation.…
Immortal time bias in a claims-database study — one year on Started this topic · Evidence › Study critique · 28 Jun 2026 · 26 likes Posting this under the heading it deserves: Immortal time bias in a claims-database study — one year on Everything below is what sits behind that. Comparing SURPASS-2 (…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #30 · Analytics › Impurities & related substances · 28 Jun 2026 · 23 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #20 · Practice › Dosing & titration · 27 Jun 2026 · 0 likes This follows post #17 rather than contradicting it. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but…
Why fasting instructions for oral semaglutide are not optional advice Replied, post #59 · Compounds › Oral incretins · 25 Jun 2026 · 3 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
Why side effects reset at each escalation and that is not a failure Replied, post #2 · Practice › Side effects · 24 Jun 2026 · 3 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
Second pass at: Programming during a large energy deficit Replied, post #34 · Nutrition & Training › Resistance training · 19 Jun 2026 · 33 likes Picking up post #31: that is the part I would want checked first. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires…
Spreadsheets: an appreciation — what changed since Replied, post #71 · Lounge › Off topic · 15 Jun 2026 · 12 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
Racemisation and why it is invisible to a mass measurement Replied, post #72 · Analytics › Impurities & related substances · 12 Jun 2026 · 0 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
An appeal that succeeded, with the letter structure — the long version Replied, post #71 · Access › Insurance & coverage · 9 Jun 2026 · 0 likes post #70 answers the question as asked. The question underneath it is different. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials…
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #12 · Evidence › Meta-analyses · 4 Jun 2026 · 6 likes This follows post #9 rather than contradicting it. Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are…
GLP-1 receptor distribution: central and peripheral Replied, post #62 · Pharmacology › Receptor biology · 3 Jun 2026 · 4 likes I read post #60 twice before replying, because I had assumed the opposite. Cross-reactivity and selectivity: the compounds are not perfectly selective for their target…
Official shortage notices and what they authorise Replied, post #83 · Access › Shortages · 2 Jun 2026 · 1 like Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #68 · Evidence › Preprints · 2 Jun 2026 · 0 likes Worth separating two things that post #64 runs together. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #14 · Practice › Storage & stability · 1 Jun 2026 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #35 · Analytics › HPLC & UHPLC · 31 May 2026 · 27 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #30 · Analytics › Home & field testing · 25 May 2026 · 0 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
Official shortage notices and what they authorise Replied, post #68 · Access › Shortages · 25 May 2026 · 23 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
Follow-up: External review after an internal denial Replied, post #2 · marked as the solution · Access › Insurance & coverage · 20 May 2026 · 20 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
Endotoxin and why it is a separate question from purity — what changed since Replied, post #21 · Analytics › Impurities & related substances · 18 May 2026 · 18 likes post #20 answers the question as asked. The question underneath it is different. Residual solvents: traces of solvents used in purification. These are usually tested by…
Prescription portability between countries Replied, post #33 · Access › International · 15 May 2026 · 3 likes This follows post #30 rather than contradicting it. Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by…
Electrolyte supplements: which ones do anything Replied, post #5 · Nutrition & Training › Hydration & electrolytes · 7 May 2026 · 21 likes Picking up post #2: that is the part I would want checked first. Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses.…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #86 · Devices › Syringes & needles · 4 May 2026 · 6 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #65 · Devices › Syringes & needles · 27 Apr 2026 · 17 likes post #64 is right about the mechanism and I think understates the practical bit. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #27 · Practice › Dosing & titration · 21 Apr 2026 · 18 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
GLP-1 receptor distribution: central and peripheral Replied, post #35 · Pharmacology › Receptor biology · 20 Apr 2026 · 0 likes Worth separating two things that post #31 runs together. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #90 · Practice › Interactions · 20 Apr 2026 · 10 likes On post #86 — agreed on the reasoning, with one qualification. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #35 · Evidence › Journal club · 19 Apr 2026 · 19 likes Picking up post #32: that is the part I would want checked first. Session format: read the paper before posting. The discussion is much better when everyone has. Start…
Coming back to: Training through a dose escalation week Replied, post #75 · Nutrition & Training › Resistance training · 9 Apr 2026 · 2 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
Preprint servers and what screening they do — the long version Replied, post #11 · Evidence › Preprints · 5 Apr 2026 · 0 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
Micro-titration: a disputed topic, argued properly Replied, post #54 · Practice › Dosing & titration · 1 Apr 2026 · 8 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #10 · Pharmacology › Formulation chemistry · 24 Mar 2026 · 0 likes post #9 is right about the mechanism and I think understates the practical bit. Lyophilisation and reconstitution: the powder is stable for extended periods if kept…
Follow-up: Search filters: what is missing Replied, post #55 · Meta › Site feedback · 17 Mar 2026 · 12 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
Oral versus injected administration claims for BPC-157 Replied, post #24 · Compounds › Repair & healing peptides · 16 Mar 2026 · 15 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #62 · Analytics › Mass spectrometry · 9 Mar 2026 · 29 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #48 · Compounds › Cagrilintide & amylin analogues · 7 Mar 2026 · 0 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #7 · Sourcing › Logistics · 27 Feb 2026 · 6 likes On post #3 — agreed on the reasoning, with one qualification. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before…
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #4 · Analytics › Mass spectrometry · 21 Feb 2026 · 2 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
[2026 update] Journal club: PIONEER 6 as a safety trial Replied, post #3 · Evidence › Journal club · 20 Feb 2026 · 23 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #56 · Outcomes › Body composition · 19 Feb 2026 · 7 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
An ABAB design with a data table and honest limitations — a second dataset Started this topic · Research Methods › N-of-1 designs · 18 Feb 2026 · 0 likes On the subject in the title: An ABAB design with a data table and honest limitations — a second dataset Working notes rather than a conclusion. Session topic: STEP 2 (…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #24 · Practice › Storage & stability · 15 Feb 2026 · 5 likes Worth separating two things that post #20 runs together. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags.…
Coverage in the US: a map of the usual obstacles Replied, post #49 · Regional › North America · 10 Feb 2026 · 0 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
Guidelines revision: what changed and why — one year on Replied, post #68 · Meta › Announcements · 8 Feb 2026 · 24 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
Trifluoroacetate content and its consequences Replied, post #44 · Analytics › Impurities & related substances · 29 Jan 2026 · 0 likes This follows post #41 rather than contradicting it. Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by…
Revisiting: Absolute versus relative contraindications Replied, post #13 · Safety › Contraindications · 27 Jan 2026 · 3 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #87 · Compounds › Oral incretins · 16 Jan 2026 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
Filter needles: when they help and what they cost you Replied, post #27 · Devices › Syringes & needles · 15 Jan 2026 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
A partial dose because the pen emptied mid-injection Replied, post #97 · Practice › Administration · 10 Jan 2026 · 2 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
Follow-up: Search filters: what is missing Replied, post #11 · Meta › Site feedback · 8 Jan 2026 · 5 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
Vomiting: when it is expected and when it is a reason to stop Replied, post #4 · Practice › Side effects · 26 Dec 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
The decimal-point error, and the habit that catches it Replied, post #31 · Practice › Reconstitution · 14 Dec 2025 · 7 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #25 · Research Methods › N-of-1 designs · 6 Dec 2025 · 0 likes I read post #23 twice before replying, because I had assumed the opposite. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar…
Hepatic steatosis: what the MASH trial evidence supports — one year on Started this topic · Clinical › Comorbidities · 28 Nov 2025 · 14 likes On the subject in the title: Hepatic steatosis: what the MASH trial evidence supports — one year on Working notes rather than a conclusion. General question, not a…
Sleep quality changes during weight loss — what changed since Replied, post #70 · Wellbeing › Sleep · 19 Nov 2025 · 13 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #18 · Devices › Pens & autoinjectors · 18 Nov 2025 · 3 likes Picking up post #15: that is the part I would want checked first. Reusability: some pens are single-use (throw away after one injection). Others can be reused until…
EMA product information as a primary source Replied, post #62 · Regional › European Union · 13 Nov 2025 · 3 likes I read post #60 twice before replying, because I had assumed the opposite. Private prescription with self-payment is legal across the EU and is the common route where…
Pooling trials with different estimands — what changed since Replied, post #50 · Evidence › Meta-analyses · 12 Nov 2025 · 4 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
Titles that describe the question, not the situation Replied, post #147 · Start Here › How to Ask · 12 Nov 2025 · 13 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #2 · Sourcing › Vendor reports · 5 Nov 2025 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #37 · Practice › Interactions · 23 Oct 2025 · 8 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #52 · Compounds › Tirzepatide · 22 Oct 2025 · 22 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
Sleep tracking data and its considerable limitations Replied, post #37 · Wellbeing › Sleep · 19 Oct 2025 · 11 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
Sleep tracking data and its considerable limitations Replied, post #28 · Wellbeing › Sleep · 18 Oct 2025 · 10 likes post #27 answers the question as asked. The question underneath it is different. Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs…
Temperature loggers worth the money — the long version Replied, post #58 · Devices › Cold chain · 17 Oct 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Where to report an adverse event officially, by region — a second dataset Replied, post #4 · Safety › Adverse events · 7 Oct 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #22 · Sourcing › Vendor reports · 7 Oct 2025 · 0 likes Picking up post #19: that is the part I would want checked first. Date the report: when the analysis was done matters. Material can degrade in storage. A report from…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #63 · Evidence › Preprints · 30 Sep 2025 · 32 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
Dead volume across syringe and needle combinations Replied, post #6 · Devices › Syringes & needles · 30 Sep 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Started this topic · Clinical › Special populations · 15 Sep 2025 · 29 likes Older adults, sarcopenia risk, and the trade-off nobody quantifies — setting out what I have, and where I think it stops being reliable. Asking about a population…
Payment method and the leverage it gives you, ranked Replied, post #6 · Sourcing › Payments · 13 Sep 2025 · 1 like No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #36 · Evidence › Journal club · 11 Sep 2025 · 7 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #9 · Analytics › Method validation · 25 Aug 2025 · 0 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #36 · Analytics › COA interpretation · 23 Aug 2025 · 9 likes post #35 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #32 · Evidence › Preprints · 21 Aug 2025 · 4 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
Second pass at: Import rules for personal quantities, by jurisdiction, dated Replied, post #3 · Sourcing › Regulatory · 20 Aug 2025 · 23 likes Coming back to the opening post, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic…
Request: a diff view for wiki revisions — the long version Replied, post #25 · Meta › Feature requests · 1 Aug 2025 · 0 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #69 · Clinical › Comorbidities · 11 Jul 2025 · 8 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #11 · Compounds › Tirzepatide · 4 Jul 2025 · 0 likes Worth separating two things that post #7 runs together. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #27 · Sourcing › Regulatory · 25 Jun 2025 · 27 likes On post #23 — agreed on the reasoning, with one qualification. Off-label use and medical practice: clinicians can prescribe approved medications off-label under some…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #123 · Clinical › Comorbidities · 24 Jun 2025 · 0 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #143 · Practice › Reconstitution · 23 Jun 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #27 · Sourcing › Regulatory · 17 Jun 2025 · 7 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #116 · Clinical › Comorbidities · 16 Jun 2025 · 0 likes Worth separating two things that post #112 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
EU-wide position versus national implementation Replied, post #10 · Regional › European Union · 11 Jun 2025 · 2 likes post #9 answers the question as asked. The question underneath it is different. Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance…
Coming back to: When "no data" is the complete and final answer Replied, post #5 · Compounds › Other compounds · 4 Jun 2025 · 7 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
Interpreting a composition change that is within the error bars Started this topic · Outcomes › Body composition · 3 Jun 2025 · 0 likes On the subject in the title: Interpreting a composition change that is within the error bars Working notes rather than a conclusion. Longitudinal report with the method…
Half-life, steady state, and accumulation worked through Replied, post #17 · Pharmacology › Pharmacokinetics · 24 May 2025 · 33 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
Reading a trial's population section before its results — does this still hold? Replied, post #78 · Evidence › Trials · 7 May 2025 · 4 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #33 · Regional › UK & Ireland · 28 Apr 2025 · 0 likes post #32 is right about the mechanism and I think understates the practical bit. Importing for personal use: importing a prescription-only medicine without a…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #20 · Evidence › Journal club · 22 Apr 2025 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Review cadence: how often is a page actually re-checked? Replied, post #20 · Documentation › Doc review · 15 Apr 2025 · 20 likes post #19 is right about the mechanism and I think understates the practical bit. Interdependencies: if updating one page requires updating related pages, posting that…
Telehealth prescribing models in the US Replied, post #82 · Regional › North America · 9 Apr 2025 · 5 likes Picking up post #79: that is the part I would want checked first. Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #68 · Compounds › Semaglutide · 7 Apr 2025 · 1 like I read post #66 twice before replying, because I had assumed the opposite. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk…
UK access routes, dated and sourced — a second dataset Replied, post #56 · Regional › UK & Ireland · 28 Mar 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #14 · Sourcing › Vendor reports · 22 Mar 2025 · 14 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
Criticising the method without criticising the authors Replied, post #47 · Evidence › Study critique · 14 Mar 2025 · 15 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #36 · Devices › Syringes & needles · 1 Mar 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Adjudicated events and why the definition matters — the long version Replied, post #22 · Evidence › Trials · 24 Feb 2025 · 10 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
Prior authorisation: what the criteria usually require Replied, post #9 · Access › Insurance & coverage · 23 Feb 2025 · 2 likes This follows post #6 rather than contradicting it. Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or…
A supplier that answers analytical questions with restated claims Replied, post #25 · Sourcing › Red flags · 16 Feb 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
A vial that will not fully dissolve: what to check and in what order Replied, post #11 · Practice › Reconstitution · 8 Feb 2025 · 2 likes Picking up post #8: that is the part I would want checked first. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #35 · Clinical › Special populations · 7 Feb 2025 · 0 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
Distinguishing a deletion sequence by mass alone Replied, post #32 · Analytics › Mass spectrometry · 30 Jan 2025 · 18 likes Coming back to post #30, because the follow-up matters more than the original answer. What mass accuracy establishes: the measured mass is consistent with a specific…
Canadian access and provincial variation Replied, post #30 · Regional › North America · 28 Jan 2025 · 1 like Coming back to post #28, because the follow-up matters more than the original answer. Private insurance gaps: some people have private insurance but medication is not…
Canadian access and provincial variation Replied, post #13 · Regional › North America · 23 Jan 2025 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #58 · Data & Tools › Calculators · 20 Jan 2025 · 30 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
Turnaround times and what they mean for a decision — one year on Replied, post #29 · Sourcing › Independent verification · 12 Jan 2025 · 10 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
Isotonicity and what happens when you get it wrong Replied, post #9 · Pharmacology › Formulation chemistry · 26 Dec 2024 · 9 likes Picking up post #6: that is the part I would want checked first. Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #13 · Compounds › Oral incretins · 25 Dec 2024 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
Coming back to: When to suspect the method rather than the sample Replied, post #104 · Analytics › Method validation · 20 Dec 2024 · 16 likes I read post #102 twice before replying, because I had assumed the opposite. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal…
Body image changing more slowly than the body Replied, post #70 · Wellbeing › Mental health · 19 Dec 2024 · 0 likes Picking up post #67: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #64 · Compounds › Semaglutide · 16 Dec 2024 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
Taste changes and food aversion, reported and discussed Replied, post #47 · Practice › Side effects · 1 Dec 2024 · 24 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Injection-site reactions: describing them precisely enough to be useful Replied, post #34 · Practice › Side effects · 29 Nov 2024 · 2 likes On post #30 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #12 · Clinical › Special populations · 20 Nov 2024 · 18 likes Coming back to post #10, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
EMA product information as a primary source — does this still hold? Replied, post #70 · Regional › European Union · 16 Nov 2024 · 10 likes Picking up post #67: that is the part I would want checked first. Italy: AIFA controls reimbursement through a note system. Weight-management indications have not…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #120 · Compounds › Other compounds · 16 Nov 2024 · 4 likes Coming back to post #118, because the follow-up matters more than the original answer. Compounds this community declines to help with, and why: there are specifics in…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #64 · Compounds › Repair & healing peptides · 15 Nov 2024 · 0 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #150 · Clinical › Bloodwork · 27 Oct 2024 · 19 likes I read post #148 twice before replying, because I had assumed the opposite. Analytical imprecision: any measurement has an error margin. A small difference in…
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #3 · Practice › Dosing & titration · 24 Oct 2024 · 2 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #70 · Clinical › Comorbidities · 20 Oct 2024 · 2 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
Progressive overload when the scale is falling — one year on Replied, post #135 · Nutrition & Training › Resistance training · 8 Oct 2024 · 28 likes On post #131 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
Food noise reducing and the disorientation that can follow Replied, post #13 · Wellbeing › Mental health · 27 Sep 2024 · 16 likes On post #9 — agreed on the reasoning, with one qualification. When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with…
Progressive overload when the scale is falling — one year on Replied, post #98 · Nutrition & Training › Resistance training · 27 Sep 2024 · 4 likes Coming back to post #96, because the follow-up matters more than the original answer. Maintenance is the goal: preserving lean mass and strength during weight loss is…
Reporting a discrepancy without making an allegation Replied, post #88 · Sourcing › Vendor reports · 23 Sep 2024 · 32 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
Food noise reducing and the disorientation that can follow Replied, post #5 · Wellbeing › Mental health · 9 Sep 2024 · 11 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #10 · Clinical › Bloodwork · 5 Sep 2024 · 21 likes Picking up post #7: that is the part I would want checked first. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #76 · Nutrition & Training › Hydration & electrolytes · 4 Sep 2024 · 0 likes Coming back to post #74, because the follow-up matters more than the original answer. Fluid intake: baseline needs increase with gastrointestinal effects and exercise.…
Reporting a discrepancy without making an allegation Replied, post #44 · Sourcing › Vendor reports · 26 Aug 2024 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
Coming back to: Pricing far outside the range, in either direction Replied, post #26 · Sourcing › Red flags · 3 Aug 2024 · 0 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
Taste changes and food aversion, reported and discussed Replied, post #6 · Practice › Side effects · 30 Jul 2024 · 1 like Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
Circumference measurements as a poor man's composition estimate Replied, post #4 · Outcomes › Body composition · 16 Jul 2024 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Resting metabolic rate: body composition affects metabolic rate. As fat…
Journal club: FLOW and the renal composite, component by component Replied, post #29 · Evidence › Journal club · 11 Jul 2024 · 8 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
Where the four-week escalation interval comes from, and what it is not Replied, post #39 · Practice › Dosing & titration · 5 Jul 2024 · 10 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…